Global Biologic Imaging Reagents Market- Market Overview:

The global biologic imaging reagents market is expected to grow from USD 3.1 billion in 2022 to USD 6.40 billion by 2030, at a CAGR of 9.50% during the Projection period 2023-2030. The growth of the biologic imaging reagents market is mainly driven owing to the growing awareness about these reagents.

Biologic imaging reagents primarily assist doctors and researchers in carrying out diagnostic or research-based tasks. In general, they support the identification of biological processes at the molecular level as well as the acquisition of diagnostic data for the identification and management of diseases, particularly in oncology, cardiology, and neurology, by medical professionals and clinicians. Biologic imaging reagents are undergoing significant technological advancement. These technologies include nanotechnology, supramolecular chemistry, protein engineering, microfluidics, and biological targeting. The emergence of novel imaging reagents and the resulting prospects have already drastically changed the biological imaging sector. The adoption of tailored medicine, which necessitates a molecular approach regarding the early diagnosis & monitoring of medications, is a result of the biologic imaging reagents market's faster growth rate. Similarly to this, the influence of ongoing genomic and proteomic research is producing disease biomarkers. The main element driving this market is the rising frequency of cancer, neurological illnesses, and cardiovascular diseases. One of the main causes of death, according to the WHO, is cardiovascular disease. Additionally, there will be a rise in the demand for biological imaging reagents due to the growing need for diagnostic imaging devices like MRI and x-ray devices brought on by the introduction of digital and portable systems and the implementation of PACS (picture archiving and communication systems).

Sample Request:- Global Biologic Imaging Reagents Market

Market Dynamics:

Drivers:                          

• High Prevalence of Cardiovascular disease

The most important factor influencing this market's growth is the prevalence of numerous cardiovascular diseases, as well as neurological disorders and cancer. Globally increasing patient awareness levels also has the effect of driving the market's total growth. Additionally, it is anticipated that rising healthcare spending and a rise in demand for secure medical treatments will boost market expansion.

Restraints:                                             

• High-Cost

High prices are anticipated to hinder market expansion. The biologic imaging reagents market is expected to face challenges due to the high funding requirements over the Projection period. Additionally, a lack of healthcare experts and restricted access to care are other factors that have a negative impact on the industry.

Opportunities:

• Growing Research and Development Activities

The market players have lucrative chances during the Projection period due to the expanding R&D activities and rising nuclear medicine awareness levels. The market for radiopharmaceuticals also offers tremendous growth potential for the biologic imaging reagents market in the coming years.

Challenges:

• Strict Government Regulation

The social segregation and movement restrictions imposed by the government through its numerous tight guidelines and laws created a barrier to the market's overall expansion. However, as various regulatory agencies start to relax these imposed lockdowns globally, the biological imaging reagents market is anticipated to rebound.

Segmentation Analysis:

The global biologic imaging reagents market has been segmented based on class, modality, application, end-user, and region.

By Class

The class segment is optical reagents, contrast reagents, and nuclear reagents. The contrast reagents segment led the largest share of the biologic imaging reagents market with a market share of around 37% in 2022. The market for contrast reagents is further divided into MRI, ultrasound, x-ray, and CT reagents. Throughout the Projection period, this market is anticipated to hold the highest share of the entire market. The high volume of diagnostic operations utilizing x-ray, ultrasound, and MRI equipment as well as the increasing popularity of these technologies is driving this segment.

By Modality

The modality segment is MRI, optical imaging, X-ray and CT, ultrasound, nuclear, and others. The MRI segment led the largest share of the biologic imaging reagents market with a market share of around 30% in 2022. MRI scanners are especially well adapted for imaging the body's soft tissues or non-bony portions. They are distinct from computed tomography (CT) in that they do not utilize x-rays' harmful ionizing radiation. Because MRI provides a far clearer view of the brain, spinal cord, and nerves than conventional x-rays and computed tomography (CT), it is frequently used to assess knee and shoulder injuries.

By End-User                                                                                     

The end-user segment is imaging centers, diagnostic laboratories, research and academic institutes, life science companies, and others. The imaging centers segment led the largest share of the biologic imaging reagents market with a market share of around 32% in 2022. Computed tomography (CT) and magnetic resonance imaging (MRI) equipment are two examples of capital-intensive resources that have historically been concentrated in imaging centers; in state healthcare systems, it is typical for hospitals to have the equipment and expertise to manage both inpatient and outpatient imaging services.

Global Biologic Imaging Reagents Market- Sales Analysis.

The sale of biologic imaging reagents market expanded at a CAGR of 8.80% from 2016 to 2022.

Biologic imaging reagents are substances used by scientists or doctors to carry out research- or diagnostic-based tasks. Healthcare and other life science businesses heavily rely on biological imaging reagents. They are extremely helpful in the molecular-level detection of biological activities. Additionally, these imaging reagents help medical professionals and doctors gather diagnostic data for the identification and management of illnesses, particularly in the fields of cardiology, oncology, and neurology.

The biologic imaging reagents market is expected to experience growth over the Projection period due to the rising demand for high-quality technology for the diagnosis of a variety of illnesses, including those affecting the nervous system, cancer, the heart, and blood vessels, as well as the growing use of symptomatic imaging techniques and rising research expenditures for updating therapeutics. While it is predicted that the industry would be hindered by rising expenses and funding needs, ongoing improvement in the market's diagnosis sector is projected to present a sizable potential.

Thus, owing to the aforementioned factors, the global biologic imaging reagents market is expected to grow at a CAGR of 9.50% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the biologic imaging reagents market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the biologic imaging reagents market and held a 37% share of the market revenue in 2022.

• The North America region witnessed a major share. Because of the accessibility of sophisticated healthcare infrastructure, the level of patient knowledge, and the rise in high per capita healthcare spending. The major position held by North America is also responsible for the quick acceptance of a wide range of modality types by end users, technological advancements, and a rise in the incidence of chronic diseases including cancer and cardiovascular disease in the region.
• Asia-Pacific is anticipated to experience significant growth during the Projection period. Due to the region's unmet medical demands and increased economic growth, which is helping nations like China and India improve their healthcare infrastructure, the market is expected to rise quickly throughout the Projection period. The biologic imaging reagents market in the region is also being driven by an increase in attractive opportunities for clinical and preclinical trials, observational studies at lower prices, and government funding in research and development activities.

Global Biologic Imaging Reagents Market- Country Analysis:

• Germany

Germany's biologic imaging reagents market size was valued at USD 0.038 billion in 2022 and is expected to reach USD 0.056 billion by 2030, at a CAGR of 5% from 2023 to 2030. The development of the biologic imaging reagents market in the region is driven by the availability of advanced healthcare infrastructure, high per capita healthcare expenditure, and patient awareness levels.

• China

China’s biologic imaging reagents market size was valued at USD 0.076 billion in 2022 and is expected to reach USD 0.140 billion by 2030, at a CAGR of 8% from 2023 to 2030. Due to the large unmet medical requirements and expanding economic growth supporting improvements in the region's healthcare infrastructure in nations like China.

• India

India's Biologic imaging reagents market size was valued at USD 0.067 billion in 2022 and is expected to reach USD 0.133 billion by 2030, at a CAGR of 7% from 2023 to 2030. Because of the highly developed healthcare infrastructure, high per-person healthcare spending, and high patient awareness levels. However, this is due to the fact that there are significant unmet medical requirements and expanding economic growth supporting the upgrading of the healthcare infrastructure in nations like India.

Key Industry Players Analysis:

To increase their market position in the global biologic imaging reagents business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.   

• Lantheus Holdings, Inc.
• General Electric Company
• Siemens AG
• Bayer AG
• Thermo Fisher Scientific Inc.
• CMC Contrast AB
• Koninklijke Philips N.V.
• Bracco Spa
• Merck & Co., Inc.
• Shimadzu Corporation

Latest Development:

• In June 2022, Agilent Technologies Inc. said that, in accordance with the new EU IVDR legislation, formerly CE-IVD marked instruments, kits, and reagents were released as IVDR Class A on May 26, 2022.
• In April 2022, Non-alcoholic steatohepatitis (NASH) is a disease that, to date, has no regulatory-approved therapeutics for treatment because it is impossible to predict human responses to this complex disease via conventional in-vivo animal studies. CN Bio, an organ-on-a-chip (OOC) company, launched its PhysioMimix "in-a-box" reagent kit for NASH.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	9.50%
Market Size	3.1 billion in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Class, By Modality, By Application, By End-User, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Lantheus Holdings, Inc., General Electric Company, Siemens AG, Bayer AG, Thermo Fisher Scientific Inc., CMC Contrast AB, Koninklijke Philips N.V., Bracco Spa, Merck & Co., Inc., and Shimadzu Corporation.
By Class	Optical Reagents Contrast Reagents Nuclear Reagents
By Modality	MRI Optical Imaging X-ray and CT Ultrasound Nuclear Others
By Application	In Vitro In Vivo
By End-User	Imaging Centers Diagnostic Laboratories Research and Academic Institutes Life Science Companies Others
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Biologic Imaging Reagents Market By Class:

• Optical Reagents
• Contrast Reagents
• Nuclear Reagents

Global Biologic Imaging Reagents Market By Modality:

• MRI
• Optical Imaging
• X-ray and CT
• Ultrasound
• Nuclear
• Others

Global Biologic Imaging Reagents Market By Application:

• In Vitro
• In Vivo

Global Biologic Imaging Reagents Market By End-User:

• Imaging Centers
• Diagnostic Laboratories
• Research and Academic Institutes
• Life Science Companies
• Others

Global Biologic Imaging Reagents Market By Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- Strong political institutions and frameworks encourage market expansion and growth for biologic imaging reagents. Government stability also enables the biologic imaging reagents market to grow both domestically and abroad. Manufacturers of the biologic imaging reagents market may quickly and smoothly maintain their business relationships with other nations because of political stability and strength. Government stability also draws investors for enterprises and corporations in the biologic imaging reagents market which promotes the expansion and development of the infrastructure and improves the country's reputation abroad. High levels of government stability can also draw resources for general industrial development, which will enhance player performance and competitive posture overall.

Economic Factors- In order for businesses like the biologic imaging reagents market to prosper, the economy needs a moderate rate of inflation. A modest rate of inflation will also aid in corporate expansion and positively influence consumer confidence and spending patterns. The economy will benefit as a result, and disposable income will rise overall. A greater inflation rate would result in less discretionary money, which could affect enterprises and companies as well as weaken consumer confidence. It would also likely lead to a decrease in overall expansion. A decreased inflation rate will result in a significant rise in disposable income, which could stimulate competition, particularly through pricing methods that could result in unethical price wars that unfairly benefit the customer.

Social Factors- Numerous factors will help the biologic imaging reagents market to make it desirable for the populace to have better levels of education. Higher education increases the number of intelligent, knowledgeable, and competent individuals available to the biologic imaging reagents market Higher levels of education also indicate that customers are more conscious of their spending and consumption habits. Because of its distinct competitive positioning and placement, the biologic imaging reagents market will benefit from its focus on healthy eating. Additionally, consumers who are more aware will value quality and be mindful of what the product claims and provides. The basis for repeat purchases will be this comparison.

Technological Factors- Technology is advancing and developing at a rapid pace. Businesses like the biologic imaging reagents market are increasingly utilizing technological advancements and innovation to boost corporate effectiveness and efficiency. All industries have a high pace of innovation, which boosts the competitiveness and success of businesses like the biologic imaging reagents market. Additionally, the upgraded technological infrastructure aids in luring foreign direct investment, which encourages additional growth and advancement. The biologic imaging reagents market benefits from a particular competitive advantage in terms of technological improvements as a result, and the biologic imaging reagents market continues to employ and take part in innovation processes to improve business cycles.

Environmental Factors-  Recycling and environmental sustainability are receiving more attention. More and more consumers are demanding ways to recycle things before disposing of them. Consumption of recycled goods is likewise becoming more and more popular with consumers. Specific ways have been developed by the manufacturers of biologic imaging reagents market for the disposal of products for recycling. Like many other businesses, manufacturers of biologic imaging reagents market is launching a brand-new product line of recycled goods for consumers. The biologic imaging reagents market should affiliate with and register with the waste management authorities and institutions in order to obey regulations, maintain checks, and prevent any future difficulties because the country has strict regulations for waste management and control.

Legal Factors- Regarding the health and safety of employees at work, there are stringent rules. Respected associations and institutions conduct routine audits of businesses to determine whether safety nets, drills, and other preventative measures are being implemented. The safety and health of employees include not only their physical health but also their emotional and mental health. Businesses must create legally binding employment contracts in accordance with national rules. These agreements, which cover every aspect of employment, are approved by respected governmental bodies. Employability agreements guarantee good communication and prevent miscommunication or collusion between all parties.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Class
     • 3.2. Market Attractiveness Analysis By Modality
     • 3.3. Market Attractiveness Analysis By Application
     • 3.4. Market Attractiveness Analysis By End-User
     • 3.5. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. High Prevalence of Cardiovascular disease
   • 3. Restraints
     • 3.1. High-Cost
   • 4. Opportunities
     • 4.1. Growing Research and Development Activities
   • 5. Challenges
     • 5.1. Strict Government Regulation

6. Global Biologic Imaging Reagents Market Analysis and Projection, By Class
   • 1. Segment Overview
   • 2. Optical Reagents
   • 3. Contrast Reagents
   • 4. Nuclear Reagents
7. Global Biologic Imaging Reagents Market Analysis and Projection, By Modality
   • 1. Segment Overview
   • 2. MRI
   • 3. Optical Imaging
   • 4. X-ray and CT
   • 5. Ultrasound
   • 6. Nuclear
   • 7. Others
8. Global Biologic Imaging Reagents Market Analysis and Projection, By Application
   • 1. Segment Overview
   • 2. In Vitro
   • 3. In Vivo
9. Global Biologic Imaging Reagents Market Analysis and Projection, By End-User
   • 1. Segment Overview
   • 2. Imaging Centers
   • 3. Diagnostic Laboratories
   • 4. Research and Academic Institutes
   • 5. Life Science Companies
   • 6. Others
10. Global Biologic Imaging Reagents Market Analysis and Projection, By Regional Analysis
    • Segment Overview
    • North America
      • 2.1. U.S.
      • 2.2. Canada
      • 2.3. Mexico
    • Europe
      • 3.1. Germany
      • 3.2. France
      • 3.3. U.K.
      • 3.4. Italy
      • 3.5. Spain
    • Asia-Pacific
      • 4.1. Japan
      • 4.2. China
      • 4.3. India
    • South America
      • 5.1. Brazil
    • Middle East and Africa
      • 6.1. UAE
      • 6.2. South Africa

11. Global Biologic Imaging Reagents Market-Competitive Landscape
    • Overview
    • Market Share of Key Players in the Biologic Imaging Reagents Market
      • 2.1. Global Company Market Share
      • 2.2. North America Company Market Share
      • 2.3. Europe Company Market Share
      • 2.4. APAC Company Market Share
    • Competitive Situations and Trends
      • 3.1. Product Launches and Developments
      • 3.2. Partnerships, Collaborations, and Agreements
      • 3.3. Mergers & Acquisitions
      • 3.4. Expansions

12. Company Profiles
    • Lantheus Holdings, Inc.
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Product Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • General Electric Company
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Product Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Siemens AG
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Product Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Bayer AG
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Product Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Thermo Fisher Scientific Inc.
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Product Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • CMC Contrast AB
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Product Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • Koninklijke Philips N.V.
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Product Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • Bracco Spa
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Product Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • Merck & Co., Inc.
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Product Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • Shimadzu Corporation
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Product Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
2. Global Optical Reagents, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
3. Global Contrast Reagents, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
4. Global Nuclear Reagents, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
5. Global Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
6. Global MRI, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
7. Global Optical Imaging, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
8. Global X-ray and CT, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
9. Global Ultrasound, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
10. Global Nuclear, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
11. Global Others, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
12. Global Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
13. Global In Vitro, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
14. Global In Vivo, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
15. Global Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
16. Global Imaging Centers, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
17. Global Diagnostic Laboratories, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
18. Global Research and Academic Institutes, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
19. Global Life Science Companies, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
20. Global Others, Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
21. Global Biologic Imaging Reagents Market, By Region, 2023–2030 (USD Billion)
22. North America Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
23. North America Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
24. North America Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
25. North America Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
26. USA Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
27. USA Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
28. USA Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)  
29. USA Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)  
30. Canada Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
31. Canada Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
32. Canada Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
33. Canada Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
34. Mexico Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
35. Mexico Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
36. Mexico Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
37. Mexico Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
38. Europe Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
39. Europe Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
40. Europe Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
41. Europe Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
42. Germany Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
43. Germany Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
44. Germany Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
45. Germany Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
46. France Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
47. France Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
48. France Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
49. France Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
50. UK Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
51. UK Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
52. UK Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
53. UK Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
54. Italy Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
55. Italy Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
56. Italy Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
57. Italy Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
58. Spain Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
59. Spain Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
60. Spain Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
61. Spain Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
62. Asia Pacific Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
63. Asia Pacific Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
64. Asia Pacific Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
65. Asia Pacific Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
66. Japan Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
67. Japan Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
68. Japan Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
69. Japan Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
70. China Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
71. China Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
72. China Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
73. China Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
74. India Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
75. India Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
76. India Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
77. India Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
78. South America Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
79. South America Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
80. South America Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
81. South America Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
82. Brazil Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
83. Brazil Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
84. Brazil Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
85. Brazil Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
86. Middle East and Africa Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
87. Middle East and Africa Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
88. Middle East and Africa Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
89. Middle East and Africa Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
90. UAE Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
91. UAE Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
92. UAE Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
93. UAE Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)
94. South Africa Biologic Imaging Reagents Market, By Class, 2023–2030 (USD Billion)
95. South Africa Biologic Imaging Reagents Market, By Modality, 2023–2030 (USD Billion)
96. South Africa Biologic Imaging Reagents Market, By Application, 2023–2030 (USD Billion)
97. South Africa Biologic Imaging Reagents Market, By End-User, 2023–2030 (USD Billion)

List of Figures 

1. Global Biologic Imaging Reagents Market Segmentation
2. Biologic Imaging Reagents Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Biologic Imaging Reagents Market Attractiveness Analysis By Class
9. Global Biologic Imaging Reagents Market Attractiveness Analysis By Modality
10. Global Biologic Imaging Reagents Market Attractiveness Analysis By Application
11. Global Biologic Imaging Reagents Market Attractiveness Analysis By End-User
12. Global Biologic Imaging Reagents Market Attractiveness Analysis By Region
13. Global Biologic Imaging Reagents Market: Dynamics
14. Global Biologic Imaging Reagents Market Share By Class (2023 & 2030)
15. Global Biologic Imaging Reagents Market Share By Modality (2023 & 2030)
16. Global Biologic Imaging Reagents Market Share By Application (2023 & 2030)
17. Global Biologic Imaging Reagents Market Share By End-User (2023 & 2030)
18. Global Biologic Imaging Reagents Market Share by Regions (2023 & 2030)
19. Global Biologic Imaging Reagents Market Share by Company (2021)